How Does Spectrum Pharmaceuticals, Inc. (SPPI) Stock Rank on Wall Street Thursday?

Thursday, November 18, 2021 10:35 AM | InvestorsObserver Analysts

Mentioned in this article

Wall Street is positive on Spectrum Pharmaceuticals, Inc. (SPPI). On average, analysts give the stock a Strong Buy rating. The average price target is $6.75, which means analysts expect the stock to increase by 268.85% over the next twelve months. That average ranking earns the stock an Analyst Rating of 54, which is better than 54% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating SPPI a Strong Buy today. Find out what this means to you and get the rest of the rankings on SPPI!
See Full SPPI Report

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Spectrum Pharmaceuticals, Inc. Stock Today?

Spectrum Pharmaceuticals, Inc. (SPPI) stock is trading at $1.83 as of 10:34 AM on Thursday, Nov 18, a loss of -$0.09, or -4.95% from the previous closing price of $1.92. The stock has traded between $1.82 and $1.95 so far today. Volume today is below average. So far 464,043 shares have traded compared to average volume of 2,050,044 shares. Click Here to get the full Stock Report for Spectrum Pharmaceuticals, Inc. stock.

Share this article:

Related Articles